Annual Net Income
-$5.00 M
-$1.45 M-40.64%
31 December 2023
Summary:
Protagenic Therapeutics annual net profit is currently -$5.00 million, with the most recent change of -$1.45 million (-40.64%) on 31 December 2023. During the last 3 years, it has fallen by -$2.45 million (-96.20%). PTIX annual net income is now -540.18% below its all-time high of $1.14 million, reached on 31 July 2000.PTIX Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$640.80 K
+$965.70 K+60.11%
30 September 2024
Summary:
Protagenic Therapeutics quarterly net profit is currently -$640.80 thousand, with the most recent change of +$965.70 thousand (+60.11%) on 30 September 2024. Over the past year, it has increased by +$755.80 thousand (+54.12%). PTIX quarterly net income is now -160.11% below its all-time high of $1.07 million, reached on 30 June 2008.PTIX Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$5.65 M
+$755.80 K+11.80%
30 September 2024
Summary:
Protagenic Therapeutics TTM net profit is currently -$5.65 million, with the most recent change of +$755.80 thousand (+11.80%) on 30 September 2024. Over the past year, it has dropped by -$1.72 million (-43.87%). PTIX TTM net income is now -572.22% below its all-time high of $1.20 million, reached on 31 July 2000.PTIX TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTIX Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.6% | +54.1% | -43.9% |
| 3 y3 years | -96.2% | +27.0% | -35.9% |
| 5 y5 years | -95.5% | -419.7% | -215.4% |
PTIX Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -96.2% | at low | -6.5% | +62.8% | -94.0% | +11.8% |
| 5 y | 5 years | -185.6% | at low | -419.7% | +62.8% | -242.2% | +11.8% |
| alltime | all time | -540.2% | +95.7% | -160.1% | +99.5% | -572.2% | +95.4% |
Protagenic Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$640.80 K(-60.1%) | -$5.65 M(-11.8%) |
| June 2024 | - | -$1.61 M(-6.8%) | -$6.40 M(+6.6%) |
| Mar 2024 | - | -$1.72 M(+2.9%) | -$6.01 M(+20.1%) |
| Dec 2023 | -$5.00 M(+40.6%) | -$1.68 M(+20.0%) | -$5.00 M(+27.4%) |
| Sept 2023 | - | -$1.40 M(+15.5%) | -$3.93 M(+13.6%) |
| June 2023 | - | -$1.21 M(+68.4%) | -$3.45 M(+18.6%) |
| Mar 2023 | - | -$718.10 K(+19.4%) | -$2.91 M(-18.1%) |
| Dec 2022 | -$3.56 M(-21.4%) | -$601.40 K(-35.0%) | -$3.56 M(-7.5%) |
| Sept 2022 | - | -$925.30 K(+38.8%) | -$3.84 M(+1.2%) |
| June 2022 | - | -$666.70 K(-51.1%) | -$3.80 M(-18.8%) |
| Mar 2022 | - | -$1.36 M(+53.0%) | -$4.68 M(+3.4%) |
| Dec 2021 | -$4.52 M(+77.5%) | -$890.40 K(+1.4%) | -$4.52 M(+8.8%) |
| Sept 2021 | - | -$878.30 K(-43.3%) | -$4.16 M(-3.9%) |
| June 2021 | - | -$1.55 M(+28.3%) | -$4.32 M(+29.3%) |
| Mar 2021 | - | -$1.21 M(+130.4%) | -$3.34 M(+26.9%) |
| Dec 2020 | -$2.55 M(+45.6%) | -$523.70 K(-49.9%) | -$2.64 M(-7.9%) |
| Sept 2020 | - | -$1.05 M(+84.4%) | -$2.86 M(+47.6%) |
| June 2020 | - | -$567.40 K(+13.8%) | -$1.94 M(+17.5%) |
| Mar 2020 | - | -$498.60 K(-33.5%) | -$1.65 M(-5.7%) |
| Dec 2019 | -$1.75 M(-31.5%) | -$749.90 K(+508.2%) | -$1.75 M(-2.2%) |
| Sept 2019 | - | -$123.30 K(-55.7%) | -$1.79 M(-17.3%) |
| June 2019 | - | -$278.50 K(-53.5%) | -$2.16 M(-15.4%) |
| Mar 2019 | - | -$599.20 K(-24.1%) | -$2.56 M(+0.0%) |
| Dec 2018 | -$2.56 M(+13.2%) | -$789.70 K(+58.7%) | -$2.56 M(+3.8%) |
| Sept 2018 | - | -$497.50 K(-25.9%) | -$2.46 M(+1.8%) |
| June 2018 | - | -$671.40 K(+12.2%) | -$2.42 M(+10.0%) |
| Mar 2018 | - | -$598.20 K(-14.1%) | -$2.20 M(-2.6%) |
| Dec 2017 | -$2.26 M(-0.7%) | -$696.10 K(+53.1%) | -$2.26 M(+6.6%) |
| Sept 2017 | - | -$454.60 K(+0.8%) | -$2.12 M(-0.0%) |
| June 2017 | - | -$451.10 K(-31.4%) | -$2.12 M(-3.3%) |
| Mar 2017 | - | -$657.90 K(+18.3%) | -$2.19 M(-3.6%) |
| Dec 2016 | -$2.28 M(+378.1%) | -$556.10 K(+22.1%) | -$2.28 M(+21.2%) |
| Sept 2016 | - | -$455.50 K(-13.2%) | -$1.88 M(+20.9%) |
| June 2016 | - | -$524.50 K(-29.1%) | -$1.55 M(+36.2%) |
| Mar 2016 | - | -$739.80 K(+368.2%) | -$1.14 M(+119.4%) |
| Dec 2015 | - | -$158.00 K(+20.6%) | -$520.00 K(+5.1%) |
| Sept 2015 | - | -$131.00 K(+17.0%) | -$495.00 K(+4.0%) |
| June 2015 | -$476.00 K(-55.9%) | -$112.00 K(-5.9%) | -$476.00 K(+3.5%) |
| Mar 2015 | - | -$119.00 K(-10.5%) | -$460.00 K(-35.3%) |
| Dec 2014 | - | -$133.00 K(+18.8%) | -$711.00 K(-10.9%) |
| Sept 2014 | - | -$112.00 K(+16.7%) | -$798.00 K(-26.1%) |
| June 2014 | -$1.08 M(+5.1%) | -$96.00 K(-74.1%) | -$1.08 M(+9.8%) |
| Mar 2014 | - | -$370.00 K(+68.2%) | -$984.00 K(+60.3%) |
| Dec 2013 | - | -$220.00 K(-44.2%) | -$614.00 K(+55.8%) |
| Sept 2013 | - | -$394.00 K(-91.3%) | -$394.00 K(-98.2%) |
| June 2013 | -$1.03 M(-94.8%) | - | - |
| Sept 2011 | - | -$4.52 M(-26.5%) | -$22.35 M(+4.1%) |
| June 2011 | - | -$6.15 M(+75.1%) | -$21.47 M(+8.4%) |
| Mar 2011 | - | -$3.51 M(-57.0%) | -$19.81 M(+0.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$19.73 M(-33.1%) | -$8.16 M(+124.6%) | -$19.73 M(-44.4%) |
| Sept 2010 | - | -$3.64 M(-19.1%) | -$35.51 M(+3.6%) |
| June 2010 | - | -$4.49 M(+30.8%) | -$34.26 M(+8.0%) |
| Mar 2010 | - | -$3.44 M(-85.7%) | -$31.72 M(+7.6%) |
| Dec 2009 | -$29.47 M(-74.5%) | -$23.95 M(+903.8%) | -$29.47 M(-75.9%) |
| Sept 2009 | - | -$2.39 M(+22.5%) | -$122.08 M(+2.0%) |
| June 2009 | - | -$1.95 M(+64.1%) | -$119.70 M(+2.6%) |
| Mar 2009 | - | -$1.19 M(-99.0%) | -$116.69 M(+0.8%) |
| Dec 2008 | -$115.77 M(+2690.2%) | -$116.56 M(>+9900.0%) | -$115.77 M(>+9900.0%) |
| Sept 2008 | - | -$6000.00(-100.6%) | -$148.00 K(-92.9%) |
| June 2008 | - | $1.07 M(-499.3%) | -$2.09 M(-48.3%) |
| Mar 2008 | - | -$267.00 K(-71.6%) | -$4.04 M(-2.5%) |
| Dec 2007 | -$4.15 M(-712.9%) | -$941.00 K(-51.7%) | -$4.15 M(+29.3%) |
| Sept 2007 | - | -$1.95 M(+119.7%) | -$3.21 M(+147.4%) |
| June 2007 | - | -$887.00 K(+138.4%) | -$1.30 M(-17.0%) |
| Mar 2007 | - | -$372.00 K(+889.4%) | -$1.56 M(-4.7%) |
| Dec 2006 | $677.00 K(-967.9%) | - | - |
| Oct 2006 | - | -$37.60 K(-96.7%) | -$1.64 M(-0.6%) |
| July 2006 | - | -$1.15 M(+163.6%) | -$1.65 M(+232.0%) |
| July 2006 | -$78.00 K(-17.5%) | - | - |
| Apr 2006 | - | -$437.00 K(+3511.6%) | -$496.50 K(+734.5%) |
| Jan 2006 | - | -$12.10 K(-74.5%) | -$59.50 K(+25.5%) |
| Oct 2005 | - | -$47.40 K(-80.1%) | -$47.40 K(-97.1%) |
| July 2005 | -$94.50 K(-95.8%) | - | - |
| July 2004 | -$2.23 M(+206.9%) | - | - |
| Apr 2003 | - | -$238.00 K(-49.9%) | -$1.64 M(+4.2%) |
| Jan 2003 | - | -$475.00 K(-0.2%) | -$1.57 M(+16.1%) |
| Oct 2002 | - | -$476.00 K(+6.3%) | -$1.35 M(+85.9%) |
| July 2002 | -$728.00 K(-605.6%) | -$448.00 K(+160.5%) | -$728.00 K(+22.6%) |
| Apr 2002 | - | -$172.00 K(-33.1%) | -$594.00 K(+48.1%) |
| Jan 2002 | - | -$257.00 K(-272.5%) | -$401.00 K(+983.8%) |
| Oct 2001 | - | $149.00 K(-147.5%) | -$37.00 K(-125.7%) |
| July 2001 | $144.00 K(-87.3%) | -$314.00 K(-1595.2%) | $144.00 K(-80.6%) |
| Apr 2001 | - | $21.00 K(-80.4%) | $742.00 K(-20.5%) |
| Jan 2001 | - | $107.00 K(-67.6%) | $933.00 K(-9.1%) |
| Oct 2000 | - | $330.00 K(+16.2%) | $1.03 M(-14.2%) |
| July 2000 | $1.14 M(-268.5%) | $284.00 K(+34.0%) | $1.20 M(+3047.4%) |
| Apr 2000 | - | $212.00 K(+6.0%) | $38.00 K(-110.2%) |
| Jan 2000 | - | $200.00 K(-60.0%) | -$374.00 K(-34.8%) |
| Oct 1999 | - | $500.00 K(-157.2%) | -$574.00 K(-25.8%) |
| July 1999 | -$674.00 K(-204.0%) | -$874.00 K(+337.0%) | -$774.00 K(-623.0%) |
| Apr 1999 | - | -$200.00 K(-166.7%) | $148.00 K(-77.2%) |
| Oct 1998 | - | $300.00 K(+525.0%) | $648.00 K(0.0%) |
| July 1998 | $648.00 K(-172.0%) | $48.00 K(-84.0%) | $648.00 K(+62.0%) |
| Apr 1998 | - | $300.00 K(0.0%) | $400.00 K(-180.0%) |
| Oct 1997 | - | $300.00 K(-250.0%) | -$500.00 K(-44.4%) |
| July 1997 | -$900.00 K | -$200.00 K(-66.7%) | -$900.00 K(+28.6%) |
| Jan 1997 | - | -$600.00 K(+500.0%) | -$700.00 K(+600.0%) |
| Oct 1996 | - | -$100.00 K | -$100.00 K |
FAQ
- What is Protagenic Therapeutics annual net profit?
- What is the all time high annual net income for Protagenic Therapeutics?
- What is Protagenic Therapeutics annual net income year-on-year change?
- What is Protagenic Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Protagenic Therapeutics?
- What is Protagenic Therapeutics quarterly net income year-on-year change?
- What is Protagenic Therapeutics TTM net profit?
- What is the all time high TTM net income for Protagenic Therapeutics?
- What is Protagenic Therapeutics TTM net income year-on-year change?
What is Protagenic Therapeutics annual net profit?
The current annual net income of PTIX is -$5.00 M
What is the all time high annual net income for Protagenic Therapeutics?
Protagenic Therapeutics all-time high annual net profit is $1.14 M
What is Protagenic Therapeutics annual net income year-on-year change?
Over the past year, PTIX annual net profit has changed by -$1.45 M (-40.64%)
What is Protagenic Therapeutics quarterly net profit?
The current quarterly net income of PTIX is -$640.80 K
What is the all time high quarterly net income for Protagenic Therapeutics?
Protagenic Therapeutics all-time high quarterly net profit is $1.07 M
What is Protagenic Therapeutics quarterly net income year-on-year change?
Over the past year, PTIX quarterly net profit has changed by +$755.80 K (+54.12%)
What is Protagenic Therapeutics TTM net profit?
The current TTM net income of PTIX is -$5.65 M
What is the all time high TTM net income for Protagenic Therapeutics?
Protagenic Therapeutics all-time high TTM net profit is $1.20 M
What is Protagenic Therapeutics TTM net income year-on-year change?
Over the past year, PTIX TTM net profit has changed by -$1.72 M (-43.87%)